Stay updated on INOVATYON: Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the INOVATYON: Ovarian Cancer Clinical Trial page.

Latest updates to the INOVATYON: Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record now presents details of the completed Phase III INOVATYON ovarian cancer study, including its treatment arms, eligibility criteria, outcomes, participating locations, and publication information.SummaryDifference100%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of study details.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about the transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check25 days agoChange DetectedThe ClinicalTrials.gov error page footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. Site chrome remains visible, but the study details are blocked.SummaryDifference18%

Stay in the know with updates to INOVATYON: Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INOVATYON: Ovarian Cancer Clinical Trial page.